CEPHALEXIN powder, for suspension

Country: Сједињене Америчке Државе

Језик: Енглески

Извор: NLM (National Library of Medicine)

Активни састојак:

CEPHALEXIN (UNII: OBN7UDS42Y) (CEPHALEXIN ANHYDROUS - UNII:5SFF1W6677)

Доступно од:

NuCare Pharmaceuticals,Inc.

INN (Међународно име):

CEPHALEXIN

Састав:

CEPHALEXIN ANHYDROUS 250 mg in 5 mL

Пут администрације:

ORAL

Тип рецептора:

PRESCRIPTION DRUG

Терапеутске индикације:

Cephalexin is indicated for the treatment of respiratory tract infections caused by susceptible isolates of Streptococcus pneumoniae and Streptococcus pyogenes. Cephalexin is indicated for the treatment of otitis media caused by susceptible isolates of Streptococcus pneumoniae , Haemophilus influenzae , Staphylococcus aureus , Streptococcus pyogenes , and Moraxella catarrhalis. Cephalexin is indicated for the treatment of skin and skin structure infections caused by susceptible isolates of the following Gram-positive bacteria: Staphylococcus aureus and Streptococcus pyogenes . Cephalexin is indicated for the treatment of bone infections caused by susceptible isolates of Staphylococcus aureus and Proteus mirabilis. Cephalexin is indicated for the treatment of genitourinary tract infections, including acute prostatitis, caused by susceptible isol

Резиме производа:

Cephalexin capsules USP— 250 mg: Swedish orange body and gray cap imprinted “TEVA” on the cap and “3145” on the body, in bottles of 100 (NDC NDC 66267-982-00 Bottles of 100mL Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Dispense in a tight, light-resistant container.

Статус ауторизације:

Abbreviated New Drug Application

Карактеристике производа

CEPHALEXIN- CEPHALEXIN POWDER, FOR SUSPENSION
NUCARE PHARMACEUTICALS,INC.
----------
HIGHLIGHTS OF PRESCRIBING INFORMATION
THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE
CEPHALEXIN SAFELY AND EFFECTIVELY. SEE FULL
PRESCRIBING INFORMATION FOR CEPHALEXIN.
CEPHALEXIN CAPSULES, CEPHALEXIN FOR ORAL SUSPENSION, AND CEPHALEXIN
TABLETS, FOR ORAL USE
INITIAL U.S. APPROVAL: 1971
INDICATIONS AND USAGE
Cephalexin is a cephalosporin antibacterial drug indicated for the
treatment of the following infections caused by
susceptible isolates of designated bacteria:
Respiratory tract infection ( 1.1)
Otitis media ( 1.2)
Skin and skin structure infections ( 1.3)
Bone infections ( 1.4)
Genitourinary tract infections ( 1.5)
To reduce the development of drug-resistant bacteria and maintain the
effectiveness of cephalexin capsules, cephalexin
for oral suspension, and cephalexin tablets and other antibacterial
drugs, cephalexin capsules, cephalexin for oral
suspension, and cephalexin tablets should be used only to treat
infections that are proven or strongly suspected to be
caused by bacteria. ( 1.6)
DOSAGE AND ADMINISTRATION
Adults and patients at least 15 years of age
The usual dose is 250 mg every 6 hours, but a dose of 500
mg every 12 hours may be administered ( 2.1)
Pediatric patients (over 1 year of age)
Otitis media: 75 to 100 mg/kg in equally divided doses
every 6 hours ( 2.2)
All other indications: 25 to 50 mg/kg given in equally
divided doses ( 2.2)
In severe infections: 50 to 100 mg/kg may be
administered in equally divided doses ( 2.2)
Duration of therapy ranges from 7 to 14 days depending on the
infection type and severity. ( 2)
Dosage adjustment is required in patients with severe and end stage
renal disease (ESRD) defined as creatinine
clearance below 30 mL/min. ( 2.3)
DOSAGE FORMS AND STRENGTHS
Capsules: 250 mg and 500 mg ( 3)
For oral suspension: 125 mg/5 mL and 250 mg/5 mL
Tablets: 250 mg and 500 mg
CONTRAINDICATIONS
Patients with known hypersensitivity to cephalexin or other members of
the cephalospo